|
Yuzhakova E.V., Shanko Zh.G., Smirnova E.N.
Asymptomatic hyperuricemia in the practice of endocrinologist: Pleiotropic action of antihyperglycemic drugs
|
№8 / 2024
|
|
Masterova M.M., Georginova O.A., Abdrakhimov D.A., Krasnova T.N.
Asymptomatic hyperuricemia in young men, identified during check-up period: Prevalence and association with population diseases
|
№4 / 2024
|
|
Mazurov V.I., Drapkina O.M., Martynov А.I., Sayganov S.А., Bashkinov R.A., Gaydukova I.Z., Sapozhnikov K.V., Tolkacheva D.G., Sableva N.A., Tsinserling А.Yu.
Meta-analysis of observational cohort studies on the relationships of asymptomatic hyperuricemia with chronic kidney disease
|
№10 / 2023
|
|
Mazurov V.I., Sayganov S.A., Bashkinov R.A., Sapozhnikov K.V., Gaydukova I.Z., Tolkacheva D.G., Sableva N.A., Inamova O.V., Petrova M.S., Zinserling А.Yu.
Effect of urate-lowering therapy on the progression of chronic kidney disease in patients with osteoarthritis and asymptomatic hyperuricemia
|
№7 / 2023
|
|
Mazurov V.I., Bashkinov R.A., Inamova O.V., Petrova M.S., Morozova K.P.
Therapy of osteoarthritis in combination with asymptomatic hyperuricemia: results of a pilot study
|
№1 / 2023
|
|
Mazurov V.I., Gaydukova I.Z., Tsinzerling A.Yu., Bashkinov R.A., Inamova O.V., Petrova M.S.
The effect of asymptomatic hyperuricemia on the frequency and structure of comorbidity patients with rheumatoid arthritis
|
№6 / 2022
|
Русский
